Bonesupport Holding AB (publ) (FRA:2B4)

Market Cap	1.14B -39.9%
Revenue (ttm)	108.54M +30.7%
Net Income	13.14M +6.3%
EPS	0.06 -67.2%
Shares Out	n/a
PE Ratio	86.85
Forward PE	41.28
Dividend	n/a
Ex-Dividend Date	n/a

Volume	9
Average Volume	20
Open	17.39
Previous Close	17.39
Day's Range	16.82 - 17.74
52-Week Range	15.50 - 30.66
Beta	n/a
RSI	51.00
Earnings Date	Apr 22, 2026

About Bonesupport Holding AB

Bonesupport Holding AB (publ), an orthobiologics company, develops and sells injectable bio-ceramic bone graft substitutes in Europe, North America, and internationally. The company provides CERAMENT Bone Void Filler, an injectable ceramic bone graft substitute that remodels to host bone; CERAMENT G, an injectable ceramic bone graft substitute that remodels to host bone and elutes Gentamicin during the critical first 30 days of bone healing, as well as treats and prevents bone infection; CERAMENT V, an injectable ceramic bone graft substitute t...

• Industry: Medical Instruments & Supplies
• Sector: Healthcare
• Founded: 1999
• Employees: 148
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: 2B4

Financial Performance

In 2025, Bonesupport Holding AB's revenue was 1.17 billion, an increase of 30.70% compared to the previous year's 898.73 million. Earnings were 142.15 million, an increase of 6.28%.

Financial numbers in SEK